Balanced massive transfusion ratios in multiple injury patients with traumatic brain injury by Peiniger, Sigune et al.
RESEARCH Open Access
Balanced massive transfusion ratios in multiple
injury patients with traumatic brain injury
Sigune Peiniger
1,2, Ulrike Nienaber
2, Rolf Lefering
2, Maximilian Braun
1,2, Arasch Wafaisade
1,2, Sebastian Wutzler
1,
Matthew Borgmann
3, Philip C Spinella
4 and Marc Maegele
1,2*, for the Trauma Registry of the Deutsche
Gesellschaft für Unfallchirurgie (TR-DGU)
Abstract
Introduction: Retrospective studies have demonstrated a potential survival benefit from transfusion strategies
using an early and more balanced ratio between fresh frozen plasma (FFP) concentration and packed red blood
cell (pRBC) transfusions in patients with acute traumatic coagulopathy requiring massive transfusions. These results
have mostly been derived from non-head-injured patients. The aim of the present study was to analyze whether a
regime using a high FFP:pRBC transfusion ratio (FFP:pRBC ratio >1:2) would be associated with a similar survival
benefit in severely injured patients with traumatic brain injury (TBI) (Abbreviated Injury Scale (AIS) score, head ≥3)
as demonstrated for patients without TBI requiring massive transfusion (≥10 U of pRBCs).
Methods: A retrospective analysis of severely injured patients from the Trauma Registry of the Deutsche Gesellschaft
für Unfallchirurgie (TR-DGU) was conducted. Inclusion criteria were primary admission, age ≥16 years, severe injury
(Injury Severity Score (ISS) ≥16) and massive transfusion (≥10 U of pRBCs) from emergency room to intensive care
unit (ICU). Patients were subdivided into patients with TBI (AIS score, head ≥3) and patients without TBI (AIS score,
head <3), as well as according to the transfusion ratio they had received: high FFP:pRBC ratio (FFP:pRBC ratio >1:2)
and low FFP:pRBC ratio (FFP:pRBC ratio ≤1:2). In addition, morbidity and mortality between the two groups were
compared.
Results: A total of 1,250 data sets of severely injured patients from the TR-DGU between 2002 and 2008 were
analyzed. The mean patient age was 42 years, the majority of patients were male (72.3%), the mean ISS was 41.7
points (±15.4 SD) and the principal mechanism of injury was blunt force trauma (90%). Mortality was statistically
lower in the high FFP:pRBC ratio groups versus the low FFP:pRBC ratio groups, regardless of the presence or
absence of TBI and across all time points studied (P < 0.001). The frequency of sepsis and multiple organ failure
did not differ among groups, except for sepsis in patients with TBI who received a high FFP:pRBC ratio transfusion.
Other secondary end points such as ventilator-free days, length of stay in the ICU and overall in-hospital length of
stay differed significantly between the two study groups, but not when only data for survivors were analyzed.
Conclusions: These results add more detailed knowledge to the concept of a high FFP:pRBC ratio during early
aggressive resuscitation, including massive transfusion, to decrease mortality in severely injured patients both with
and without accompanying TBI. Future research should be conducted with a larger number of patients to prove
these results in a prospective study.
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Hemorrhage is one of the main causes of death after
trauma. Approximately 40% of severely injured patients
die as a result of acute exsanguination [1]. Uncontrolled
hemorrhage after trauma is often associated with acidosis,
hypothermia and coagulopathy, forming the so-called
“lethal triad” [2]. Recently, acute traumatic coagulopathy
(ATC) has been identified as a key factor to trigger
ongoing hemorrhage after trauma [3]. Ongoing hemor-
rhage, when combined with ATC, is frequently not con-
trolled by current resuscitation protocols using crystalloids
and transfusion of packed red blood cell (pRBC) concen-
trates [2]. As a consequence, several authors have advo-
cated the early use of fresh frozen plasma (FFP) to control
ATC in the early phase after trauma. Despite persistent
conflicting data on this issue due to suboptimal methodol-
ogies, different retrospective studies have demonstrated a
survival benefit of transfusion strategies using an early and
more balanced ratio between FFP and pRBC transfusions
in patients with ATC requiring massive transfusion within
the first 24 hours after hospital admission (≥10 U of
pRBCs) [2,4-11]. These analyses, however, have not
attempted to determine whether patients with severe trau-
matic brain injury (TBI) had the same association of
improved survival with increased FFP:pRBC ratios. Head-
injured patients are particularly prone to developing acute
coagulation disorders, and the frequency of these disorders
upon emergency room (ER) arrival in patients with blunt
TBI has been reported to be as high as 22.7% [12]. In
patients with TBI, there is a component of local tissue
release of thromboplastin and low platelets. The aim of
the present study was to analyze whether a transfusion
regimen using a high FFP:pRBC ratio (FFP:pRBC ratio
>1:2) would be associated with a similar survival benefit in
severely injured patients with TBI (AIS score, head ≥3) as
previously demonstrated for patients without TBI requir-
ing massive transfusion (≥10 U of pRBCs).
Materials and methods
We conducted a retrospective analysis of data from
severely injured patients documented in the TraumaR-
egistry of the Deutsche Gesellschaft für Unfallchirurgie
(TR-DGU).
The TraumaRegistry of the Deutsche Gesellschaft für
Unfallchirurgie
The TR-DGU was founded in 1993 by the German
Society of Trauma Surgery (Deutsche Gesellschaft für
Unfallchirurgie (DGU)). It is a prospective, multicenter,
standardized and anonymous documentation of multiply
injured trauma patients at four consecutive posttrauma
phases from injury to hospital discharge: (1) prehospital
phase, (2) emergency room and initial surgery (until
admission to the intensive care unit (ICU)), (3) ICU and
(4) outcome status at discharge and description of inju-
ries and procedures. The registry contains detailed infor-
mation on patient demographics; injury patterns;
comorbidities; pre- and in-hospital management; time
course; relevant laboratory findings, including data on
transfusions; and the outcome of each patient. All inju-
ries are coded using the Abbreviated Injury Scale (AIS).
Through 2008 data from a total of 42,248 trauma
patients had been entered into the registry, with
approximately 6,000 new cases added each year. Since
the introduction of the online version of the registry in
2002, the use of FFP has routinely been documented.
Between 2002 and 2008, 31,124 patients were entered
into the registry. There are 166 hospitals affiliated with
the registry, mostly in Germany (n = 107), of which 116
actually contribute data to the database. Contributing
hospitals are mostly level I trauma centers. The data are
not dominated by single trauma centers, but this does
not exclude potential center effects due to different
levels and strategies of trauma care. The TR-DGU is a
voluntary registry, and participation is free of charge.
T h et r a u m ar e g i s t r yi sa p p r o v e db yt h er e v i e wb o a r do f
the German Society of Trauma Surgery (DGU) and is in
compliance with the institutional requirements. As the
TR-DGU is an anonymous registry, the Institutional
Review Board waived the need for informed consent.
Data analysis
Inclusion criteria for the present analysis were primary
admission, patient age ≥16 years, severe injury (ISS ≥16)
and massive transfusion (≥10 U of pRBCs) from the ER
until ICU admission. Patients who died within the first
hour after admission were excluded. Patients were subdi-
vided into patients with TBI (AIS score, head ≥3) and
patients without TBI (AIS score, head <3) and according
to the ratio of plasma to blood that they received during
the initial massive transfusion: high (FFP:pRBC ratio >1:2)
or low (FFP:pRBC ratio ≤1:2). The FFP:pRBC ratio distri-
bution is shown in Figure 1. All transfused FFP was fresh
and frozen (that is, no thawed plasma). Only pRBCs and
FFP that had been transfused between ER and ICU admis-
sions were considered. The mean time (± standard devia-
tion (SD)) from ER arrival to ICU admission, including
emergency operative procedure time, was 331 ± 144 min-
utes. The mean time (±SD) required for initial diagnostic
procedures and treatment in the ER was 65 ± 42 minutes.
The primary outcome was mortality (6 hours, 24 hours
30 days as well as overall in-hospital mortality). Second-
ary outcomes included sepsis (defined by Bone et al. [13]
as adequate symptoms in combination with evidence of
germs), multiorgan failure (defined by Sepsis-Related
Organ Failure Assessment score ≥3), ventilator-free days
Peiniger et al. Critical Care 2011, 15:R68
http://ccforum.com/content/15/1/R68
Page 2 of 9(calculated for a total of 30 days), ICU length of stay and
hospital length of stay (HLOS).
Statistical analysis
Demographic and clinical data are presented as means ±
SD for continuous variables and as percentages for cate-
gorical variables. For continuous variables, normal distri-
butions were analyzed by using the Shapiro-Wilk test. To
detect differences between the patient groups, Student’s
t-test or the Mann-Whitney U test was performed,
depending on the underlying distribution. For categorical
variables, a c
2 test was used. Thirty-day survival rates are
presented using Kaplan-Meier curves, and differences
among the subgroups with and without TBI were tested
using the log-rank test.
Multivariate logistic regression analysis was performed
with hospital mortality as the dependent variable.
Results are presented as odds ratios (ORs) with 95%
confidence intervals (95% CIs). The following variables
were considered as independent predictors: (1) transfu-
sion ratio (FFP:pRBC ratio ≤1:2 and FFP:pRBC ratio
>1:2), (2) Revised Injury Severity Classification (RISC)
s c o r ea sas u m m a r ym e a s u r ef o rk n o w nr i s kf a c t o r sf o r
mortality and (3) emergency operations. The RISC score
was developed on the basis of data from the TR-DGU
to calculate the probability of death for individual
patients on the basis of the following 11 variables: age,
new ISS, head injury, severe injuries of the extremities,
Glasgow Coma Scale score, partial thromboplastin time,
base excess, cardiac arrest and indirect signs of bleeding
(systolic blood pressure <90 mmHg, hemoglobin <9 g/dl
and massive transfusion during initial resuscitation) [14].
A comparison with other established scores (for exam-
ple, Revised Trauma Score and Trauma Injury Severity
Score) demonstrated the superior precision, discrimina-
tion and calibration of the RISC score. Statistics were
calculated using the SPSS version 18 software package
(SPSS, Inc., Chicago, IL, USA).
Results
A total of 1,250 data sets of severely injured patients
derived from the TR-DGU between 2002 and 2008 were
eligible for analysis. The mean patient age (±SD) was
41.8 ± 16.3 years, the vast majority of patients were
male (72.3%), the mean injury severity (±SD) reflected
by ISS was 41.7 ± 15.4 points and the mechanism of
injury was predominantly blunt force trauma (90%).
Patients were divided into four subgroups as described
above and as shown in Figure 1. Table 1 summarizes
the demographic and physiological characteristics of
patients within their respective subgroups. As expected,
patients with TBI had sustained a higher overall magni-
tude of injury as compared to patients without TBI (P <
0.001). Patients without relevant TBI and a high FFP:
pRBC ratio were slightly younger and more frequently
male than patients who received a low FFP:pRBC ratio
transfusion. Physiological variables such as heart rate
and blood pressure both at the trauma scene and upon
ER arrival were comparable between all groups. Patients
in the low FFP:pRBC ratio groups were slightly more
shocked than patients with a high FFP:pRBC ratio upon
ER admission as reflected by lower base excess. The
volume loading during the prehospital and early in-
hospital phases of care did not differ among the groups,
except for the amount of crystalloids in the ER in
patients with TBI (Table 2). Among all subgroups, the
vast majority (>80%) of patients presented with manifest
clinical and laboratory signs of coagulopathy upon ER
arrival (Table 1). The number of transfused pRBC units
was comparable across all subgroups, while the amount
of plasma transfused differed considerably between the
groups according to the definition given in Table 2.
In general, the mortality rate was lower in the high FFP:
pRBC ratio groups as compared to the low FFP:pRBC
ratio groups, regardless of the presence or absence of TBI
and across all time points (Table 3 and Figures 2 and 3).
Figure 4 shows Kaplan-Meier 30-day survival curves for
 Primary admission, age16, ISS16, massive transfusion, >10pRBC 
n=1250 
Without TBI (AIS head<3) 
n=638 
With TBI (AIS head3) 
n=612 
FFP:pRBC1:2 
n=212 
FFP:pRBC>1:2 
n=426 
FFP:pRBC1:2 
n=167 
FFP:pRBC>1:2
n=445 
Figure 1 Flowchart of analyzed patients. pRBC, packed red blood cell; ISS, Injury Severity Score; TBI, traumatic brain injury; AIS, Abbreviated
Injury Scale; FFP, fresh frozen plasma.
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patients without TBI who received a high FFP:pRBC
ratio. The lowest survival rates were found in patients
with TBI who were transfused with a low FFP:pRBC
ratio. The differences in survival between the high and
low FFP:pRBC ratio groups were statistically significant
within each TBI subgroup (P < 0.001; log-rank test). The
frequency of sepsis and multiple organ failure did not dif-
fer among the groups, except for sepsis in patients with
TBI who were transfused with a high FFP:pRBC ratio
(>1:2). Other secondary end points, such as ventilator-
free days, ICU length of stay and overall in-hospital
length of stay differed significantly between the ratio
groups, but not when analyzed for survivors only.
Table 1 Basic characteristics and physiological data of patients according to their study groups
a
AIS score, head <3 AIS score, head ≥3
Patient characteristics FFP:pRBC ratio ≤1:2 FFP:pRBC ratio >1:2 P value FFP:pRBC ratio ≤1:2 FFP:pRBC ratio >1:2 P value
Number of patients (%) 212 (17%) 426 (34.1%) 167 (13.4%) 445 (35.6%)
Mean age, yr (±SD) 45.9 ± 20 42.0 ± 17.2 0.049 40.5 ± 19.2 40.2 ± 18.2 0.947
Males, n (%) 149 (70.3%) 330 (77.5%) 0.048 111 (66.5%) 314 (70.6%) 0.327
Blunt trauma mechanism, n (%) 191 (90.1%) 379 (89%) 0.722 158 (94.6%) 417 (93.7%) 0.676
Mean ISS, points (±SD) 36.7 ± 15.3 35.4 ± 13.5 0.532 49.5 ± 14.9 47.2 ± 14.1 0.143
Mean GCS at trauma scene,
points
10 12 0.001 7 7 0.571
Mean HR at trauma scene,
beats/min (±SD)
105 ± 31 106 ± 25 0.907 106 ± 33 105 ± 28 0.240
Mean HR at hospital admission,
beats/min (±SD)
105 ± 27 102 ± 26 0.222 103 ± 31 104 ± 26 0.686
Mean systolic BP at trauma
scene, mmHg (±SD)
91 ± 34 95 ± 31 0.245 90 ± 35 93 ± 35 0.792
Mean systolic BP at hospital
admission, mmHg (±SD)
93 ± 36 95 ± 30 0.411 92 ± 34 96 ± 30 0.313
Mean Hb, g/dl (±SD) 8.0 ± 2.7 8.4 ± 2.8 0.09 8.0 ± 2.9 8.4 ± 3.0 0.13
Mean BE, mM/l (±SD) -8.9 ± 6.8 -7.0 ± 5.9 0.08 -9.3 ± 6.5 -7.3 ± 6.4 0.01
Mean PTT, seconds (±SD) 51.9 (±32.8) 50.9 (±31.1) 0.63 72.3 (±49.3) 60.7 (±37.5) 0.06
Mean quick, % (±SD) 54 (±23.7) 56 (±23.4) 0.33 54 (±24.2) 53 (±23.0) 0.69
Mean platelets, nl (±SD) 158 (±77.7) 165 (±75.6) 0.30 152 (±74.0) 160 (±71.6) 0.23
Coagulopathy, n (%) 152 (87.4%) 298 (82.3%) 0.14 118 (90.1%) 344 (88.4%) 0.61
aAIS, Abbreviated Injury Scale; FFP, fresh frozen plasma; pRBC, packed red blood cell; SD, standard deviation; ISS, Injury Severity Score; GCS, Glasgow Coma Scale;
HR, heart rate; BP, blood pressure; Hb, hemoglobin; BE, base excess; PTT, partial thromboplastin time. Coagulopathy was defined by the presence of at least one
of the following conditions: PTT <38 seconds, Quick <70% and platelets <100,000/μl. In the TR-DGU the prothrombin time (PT) is documented as Quick’s value
where a value of <70% is equivalent to an INR (International Normalized Ratio) > 1.3.
Table 2 Fluids and blood products transfused during initial resuscitation
a
AIS score, head <3 AIS score, head ≥3
Transfusions and time
intervals
FFP:pRBC ratio ≤1:2 FFP:pRBC ratio >1:2 P value FFP:pRBC ratio ≤1:2 FFP:pRBC ratio >1:2 P value
Fluids prehospital
Mean crystalloids, ml (±SD) 1,491 ± 937 1,391 ± 819 0.433 1,354 ± 888 1,297 ± 743 0.981
Mean colloids, ml (±SD) 991 ± 615 939 ± 579 0.272 982 ± 654 945 ± 475 0.957
Fluids emergency room
Mean crystalloids, ml (±SD) 3,549 ± 2,858 3,981 ± 2,959 0.071 3,122 ± 2,640 4,000 ± 3,036 <0.001
Mean colloids, ml (±SD) 1,648 ± 1,478 1,802 ± 1,592 0.080 1,568 ± 1,247 1,788 ± 1,371 0.112
Mean pRBC transfusion, n (±SD) 19.5 ± 11.2 19.5 ± 11.9 0.916 18.4 ± 9.8 18.9 ± 10.7 0.980
Mean FFP transfusion, n (±SD)
(min-max)
5.7 ± 5.2 (0 to 32) 18.0 ± 12.3 (6 to 88) <0.001 5.5 ± 4.8 (0 to 30) 17.8 ± 10.4 (6 to 84) <0.001
Mean minutes from trauma
scene to ER (±SD)
59 (±39) 64 (±40) 0.115 66 (±44) 69 (±44) 0.464
Mean minutes from hospital
admission including ER and
operation theater to ICU
transfer (±SD)
303 (±144) 350 (±140) <0.001 290 (±147) 337 (±143) 0.001
aAIS, Abbreviated Injury Scale; FFP, fresh frozen plasma; pRBC, packed red blood cell; SD, standard deviation; ER, emergency room; ICU, intensive care unit.
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formed according to the presence or absence of TBI
with hospital mortality as the dependent variable. The
analysis identified a high FFP:pRBC transfusion ratio
(>1:2) as an independent predictor for survival in both
subgroups (Table 4). Interestingly, severely injured
patients who had sustained a TBI obviously benefited
more from the high FFP:pRBC ratio strategy as com-
pared to patients without TBI (ORs, 0.48 vs. 0.70). In
both groups, the RISC score was independently asso-
ciated with mortality. Multivariate analysis was also
used to calculate all RISC score variables entered into
the model, instead of the cumulative score, which
yielded the same results. The additional consideration
of emergency craniotomy in the TBI group did not
improve the model (OR, 1.1; P =0 . 6 ) .
Discussion
Although there is still debate about the early and aggres-
sive use of FFP in a more balanced 1:1 ratio to pRBCs to
correct ATC, the majority of studies published to date
have emphasized its use and have associated this approach
with improved survival rates among severe trauma
patients requiring massive transfusions [4,6-11,15,16].
These studies, however, have not attempted to determine
whether TBI patients have the same association of
improved survival with a more balanced transfusion of
FFP and pRBCs. In patients with TBI, there is a compo-
nent of local tissue release of thromboplastin and low pla-
telets. In the present study, we retrospectively investigated
whether a high FFP:pRBC transfusion ratio (FFP:pRBC
ratio >1:2) during massive transfusion (≥10 U of pRBCs)
in the acute phase after trauma would be associated with a
Table 3 Morbidity and mortality according to study groups
a
AIS score, head <3 AIS score, head ≥3
Morbidity and mortality FFP:pRBC ratio ≤1:2 FFP:pRBC ratio >1:2 P value FFP:pRBC ratio ≤1:2 FFP:pRBC ratio >1:2 P value
Sepsis, n (%) 31 (21.5%) 91 (23.6%) 0.608 19 (15.7%) 98 (24.9%) 0.035
Multiorgan failure, n (%) 86 (58.5%) 211 (55.7%) 0.557 80 (67.2%) 276 (71.3%) 0.393
Mean ventilator-free days (±SD) 8.7 ± 11.2 12.8 ± 11.6 <0.001 4.3 ± 8.1 6.1 ± 9.0 0.006
Survivors’ mean ventilation-free
days (±SD)
16.9 ± 10.2 17.4 ± 10.1 0.647 11.5 ± 9.6 11.1 ± 9.7 0.825
Mean ICU LOS, days (±SD) 14.7 ± 19.4 18.5 ± 20.1 <0.001 12.5 ± 18.5 18.2 ± 21.3 <0.001
Survivors’ mean ICU LOS, days (±SD) 24.7 ± 20.5 23.1 ± 20.6 0.335 29.0 ± 20.8 29.7 ± 22.3 0.703
Mean HLOS, days (±SD) 30.2 ± 40.3 43.3 ± 40.2 <0.001 20.6 ± 30.1 29.9 ± 36.4 <0.001
Survivors’ mean HLOS, days (±SD) 54.3 ± 43.0 56.3 ± 38.5 0.361 49.2 ± 32.3 49.9 ± 36.8 0.934
6-hour mortality, n (%) 74 (34.9%) 45 (10.6%) <0.001 55 (32.9%) 69 (15.5%) <0.001
24-hour mortality, n (%) 85 (40.1%) 47 (17.4%) <0.001 74 (44.3%) 110 (24.7%) <0.001
30-day mortality, n (%) 97 (45.8%) 105 (24.6%) <0.001 104 (62.3%) 199 (44.7%) <0.001
In-hospital overall mortality, n (%) 102 (48.1%) 114 (26.8%) <0.001 104 (62.3%) 203 (45.6%) <0.001
aAIS, Abbreviated Injury Scale; FFP, fresh frozen plasma; pRBC, packed red blood cell; ICU, intensive care unit; LOS, length of stay; SD, standard deviation; HLOS,
hospital length of stay.
Figure 2 Mortality among non-traumatic brain injury (non-TBI)
patients according to fresh frozen plasma to packed red blood
cell (FFP:pRBC) ratios transfused. Mortality rates are shown at 6
hours, 24 hours and 30 days for severely injured patients without
TBI (Abbreviated Injury Scale (AIS) score, head <3) who had received
a massive transfusion with a high or low FFP:pRBC ratio.
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Figure 3 Mortality for traumatic brain injury (TBI) patients
according to fresh frozen plasma to packed red blood cell
(FFP:pRBC) ratios transfused. Mortality rates are shown at 6 hours,
24 hours and 30 days for severely injured patients with TBI
(Abbreviated Injury Scale (AIS) score, head ≥3) who had received a
massive transfusion with a high or low FFP:pRBC ratio.
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viously observed for patients without TBI.
As we describe in the Results, the rates for acute and
late mortality were both lower in high FFP:pRBC ratio
groups compared to low FFP:pRBC ratio groups, regard-
less of the presence or absence of TBI. Despite the fact
that mortality rates in patients with TBI were generally
higher compared to patients without TBI, obviously due
to the higher magnitude of overall injury sustained, this
result indicates that the concept of a high transfusion
ratio approach in the acute trauma setting requiring
massive transfusion may also be beneficial for patients
with accompanying TBI. This assumption is further sup-
ported by the results from our logistic regression analy-
sis, which identified a high FFP:pRBC ratio to be an
independent predictor for survival, especially in TBI
patients. As the high FFP:pRBC ratio effect on survival
has been observed as an early effect, immediate intro-
duction of this approach after ER admission may be of
crucial importance as soon as clinical and laboratory
signs indicate an individual at risk for massive transfu-
sion. To support the clinician, several scoring systems to
enable early identification of patients at risk for massive
transfusion and to predict the probability for massive
transfusion at a very early stage have been developed
and validated, such as the Assessment of Blood Con-
sumption score or the predictive model for massive
transfusion described by Cotton et al.[ 1 7 ]a n d
McLaughlin et al. [18]. Recently, our group [19,20] has
introduced the Trauma Associated Severe Hemorrhage
score as a useful instrument to calculate the probability
of massive transfusion as a surrogate for life-threatening
hemorrhage after severe trauma.
Patients with TBI are at increased risk for developing
coagulation abnormalities in the acute phase after
trauma, and the clinical frequency of these disorders in
blunt TBI patients has been estimated to be as high as
22.7% [12]. The coagulopathy after TBI is thought to be
the result of injury-mediated local release of thrombo-
plastin into the systemic circulation, although the pre-
cise mechanisms that cause systemic coagulopathy after
TBI are as yet unknown [12,21,22]. In 1979, Mauersber-
ger [23] concluded on the basis of his clinical investiga-
tions that the release of tissue thromboplastin after
severe brain injury can lead to a consumption coagulo-
pathy. Hulka et al. [24] reported a similar coagulopathy
after blunt TBI that was associated with a high fre-
quency of death. These observations regarding the early
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Figure 4 The 30-day survival rates for patients with different
transfusion regimes subdivided into patients with and without
traumatic brain injury (TBI). Kaplan-Meier analysis was performed
to assess the outcomes of severely injured patients who had
received a high FFP:pRBC ratio transfusion (FFP:pRBC >1:2) versus
those who had received a low FFP:pRBC ratio transfusion (FFP:EK
≤1:2), subdivided into patients with TBI (Abbreviated Injury Scale
(AIS) score, head ≥3) and patients without TBI (AIS score, head <3).
Table 4 Logistic regression analysis
a
Non-TBI versus TBI patients Regression coefficient b Standard error of the mean P value Odds ratio (95% CI)
No TBI
FFP:pRBC ratio >1:2 -0.36 0.28 0.200 0.70 (0.04 to 1.21)
RISC score 0.75 0.09 <0.001 2.13 (1.77 to 2.56)
Emergency operation 0.09 0.30 0.759 1.10 (0.61 to 1.98)
Constant 0.02 0.26 0.947 1.02
TBI
FFP:pRBC ratio >1:2 -0.73 0.27 0.006 0.48 (0.29 to 0.81)
RISC score 0.56 0.07 <0.001 1.75 (1.52 to 2.02)
Emergency operation 0.45 0.29 0.112 1.57 (0.90 to 2.75)
Constant 0.14 0.24 0.543 1.16
aTBI, traumatic brain injury; 95% CI, 95% confidence interval; FFP, fresh frozen plasma; pRBC, packed red blood cell; RISC, Revised Injury Severity Classification.
Logistic regression analysis was performed with mortality as a dependent variable and FFP:pRBC ratio, RISC score and emergency operations as independent
variables according to the presence or absence of TBI.
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recently, Cohen et al. [25] emphasized the role of hypo-
perfusion and the protein C pathway for the develop-
ment of coagulopathy after TBI. These authors
concluded that TBI alone does not initiate coagulopathy,
but must be coupled with hypoperfusion to lead to coa-
gulation derangement associated with the activation of
the protein C pathway.
One criticism associated with transfusion of high
volumes of FFP during early acute resuscitation after
trauma has been related to its potential harmful effects
[26]. Potential risks of FFP transfusion include transfu-
sion-related acute lung injury (TRALI) [27], transfusion-
associated circulatory overload [28], allergic reaction
and transmission of infectious diseases such as human
immunodeficiency virus, hepatitis B and C viruses and
prion diseases [26]. To date, TRALI is the most impor-
tant cause of transfusion-associated morbidity and mor-
tality [29]. In previous retrospective studies, a trend was
observed in that the survival benefit associated with the
high FFP:pRBC ratio approach was bought on the
account of increasing frequencies of complications, such
as nosocomial infections, sepsis and organ failure, result-
ing in prolonged days on ventilators and increased ICU
and overall in-hospital stays [16,30]. When considering
all patients included in the present study, survivors’ and
nonsurvivors’ duration of ventilation, ICU length of stay
and HLOS were significantly longer for patients who
had received a high FFP:pRBC transfusion ratio. This
observation might be due to prolonged survival among
patients with a high FFP:pRBC transfusion ratio. When
focusing on survivors only, the duration of ventilation,
ICU length of stay and HLOS did not differ statistically
between the high and low FFP:pRBC transfusion ratio
groups. The incidence of multiple organ failure was
higher in patients with more severe injuries, including
TBI, than in patients without TBI (67% and 71% versus
59% and 56% according to the transfusion ratios, respec-
tively), but did not differ when the transfusion regimens
within the two subgroups were compared. Patients with
TBI who received a high FFP:pRBC transfusion ratio
developed septic coagulation more often than patients
of the same group but with a low FFP:pRBC transfusion
ratio.
The present observations are limited by the number of
included patients and the study’s retrospective design. It
should also be mentioned that the observed positive
effect of the high FFP:pRBC transfusion ratio could be
explained at least in part by a selection bias. This means
that patients in whom it was possible to administer
large amounts of plasma in parallel to pRBC transfusion
did not show a dramatic massive blood loss, which
would require quick transfusion of large amounts of
blood. Administration of FFP usually requires some
time for preparation. To minimize this survivorship bias,
we excluded ap r i o r ipatients who died within the first
hour after admission and limited the duration of trans-
fusion to initial resuscitation; that is, only blood pro-
ducts were considered that had been transfused between
the time of ER arrival and ICU admission. Snyder et al.
[31] additionally included the FFP:pRBC transfusion
ratio as a time-dependent covariate in their multivariate
analysis. However, since the exact timing of transfusion
is not documented in the TR-DGU, and only the cumu-
lative amount of transfused blood products between the
time of ER arrival and ICU admission is recorded, we
were not able to adjust for survivorship bias in our
logistic regression model as was done by Snyder et al.
[31]. Furthermore, this study is based on registry data
only and is thus limited by the lack of a more detailed
description of the coagulation management that was
performed, for example, platelet transfusion or the
administration of other specific coagulation factors. In
this context, Perkins et al. [32,33] and Holcomb et al.
[4] previously described the association between the
amount of transfused platelets and improved survival.
Future research should be conducted with larger patient
numbers and using a prospective approach to prove
these results.
Conclusions
Despite the ongoing debate with regard to the early,
a g g r e s s i v eu s eo fF F Pi nam o r eb a l a n c e d1 : 1r a t i ot o
pRBCs in the acute trauma setting to correct coagula-
tion disorders, the present study provides some more
detailed information in favor of this approach. The mor-
tality rates were consistently lower in the high FFP:
pRBC transfusion ratio groups versus the low FFP:pRBC
transfusion ratio groups, regardless of the presence or
absence of TBI and at all time points studied, indicating
that the concept of a high FFP:pRBC transfusion ratio
may also be valid for patients with TBI. Regarding survi-
vors, morbidity was comparable for patients with a low
or high FFP:pRBC transfusion ratio, regardless of the
presence or absence of TBI.
Key messages
￿ Retrospective studies have demonstrated a poten-
tial survival benefit from transfusion strategies using
an early and more balanced ratio between FFP and
pRBC transfusions in patients with ATC requiring
massive transfusion but results have mostly been
derived from non-head injured patients.
￿ A total of 1,250 data sets of severely injured
patients from the TR-DGU from 2002 to 2008 were
analyzed to determine whether a transfusion regime
using a high FFP:pRBC ratio (FFP:pRBC >1:2) would
be associated with a similar survival benefit in
Peiniger et al. Critical Care 2011, 15:R68
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Page 7 of 9severely injured patients with TBI (AIS score, head
≥3) as demonstrated for patients without TBI requir-
ing massive transfusion (≥10 U of pRBCs).
￿ The mortality rates were consistently lower in the
high-ratio groups versus the low-ratio groups,
regardless of the presence or absence of TBI and at
all time points studied (P < 0.001).
￿ The concept of a high FFP:pRBC ratio may also be
valid for patients with TBI. Multivariate logistic
regression analysis identified a high FFP:pRBC ratio
as an independent predictor of survival, especially in
TBI patients.
￿ Future research should be conducted with a larger
number of patients to prove these results in a pro-
spective study.
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